Web Content Management

PRODUCTS

  • A low‑risk, ultra‑efficient way to manage patient randomization and investigational product (IP) supply—fully unified within the TrialKit platform.

  • Digitize batch records to eliminate paper, reduce errors, and accelerate execution.

  • The Challenge: Building Scalable Viral Vector Programs

    Cell and gene therapies offer unprecedented hope for previously untreatable diseases. At the heart of many of these advanced therapies, including both gene therapies and gene-modified cell therapies, are viral vectors, particularly Adeno-Associated Vectors (AAV) and Lentiviral Vectors (LVV), which serve as crucial gene-delivery vehicles.

  • The success of a biotech drug development program often depends on the relationship it forms with its Clinical Research Organization (CRO) partner.

    Avance Clinical, a global CRO with more than 3 decades of experience, has an impressive track record in the US with over 200 US studies including 140 in oncology.

  • Purpose-built with users at the center to make it easier and more efficient to get quality patient outcomes data for submissions and approvals.

    Collecting quality data on patient outcomes is often one of the most important parts of a clinical trial. It is also challenging, and many eCOA solutions make it feel even more difficult with complicated processes, lack of questionnaire reusability, slow set up, and difficult to use tech.

WHITE PAPERS AND CASE STUDIES

NEWS